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Linkage heterogeneity of end-stage renal disease on human the marked familial aggregation of ESRD in families of
chromosome 10. different racial and ethnic backgrounds [reviewed in 1].
Background. The human syntenic region of the rodent renal Subsequent population-based, case-control studies andfailure-1 gene (Rf1), an attractive candidate region for end-
segregation analyses support the existence of renal fail-stage renal disease (ESRD) susceptibility, is located on chro-
ure susceptibility genes in diabetic and non-diabetic (hy-mosome 10q24-q26. In an attempt to assess for linkage between
markers on human chromosome 10 and ESRD, we performed pertension and glomerulonephritis) etiologies of nephrop-
a linkage analysis in 356 African American sib pairs concordant athy [2–4]. In families with autosomal dominant variants
for ESRD [199 sib pairs concordant for non-diabetic etiologies of focal and segmental glomerulosclerosis (FSGS), linkage(hypertension-associated, chronic glomerulonephritis and un-
has been detected on chromosomes 1, 11, and 19 [5–7]known) and 157 sib pairs concordant for diabetic ESRD].
and mutations in the a-actinin-4 gene on chromosomeMethods. Linkage was tested between 30 polymorphic
markers spanning chromosome 10 and ESRD using Gene- 19 have been identified in linked FSGS families. Markers
Hunter software. on chromosome 6 are linked with autosomal dominant
Results. In all 356 sib pairs, the maximum likelihood ratio IgA nephropathy, as well [8]. Linkage analyses in com-z-score (Zlr) occurred near locus D10S677 (Zlr  3.33, P 
mon, complex forms of ESRD are now underway. Imper-0.0004, lod  3.40), with a lesser peak near D10S1435 (Zlr 
atore et al reported linkage between markers on chromo-1.77, P  0.04, lod  1.42). The locus at D10S677 contributed
significantly to both diabetic ESRD (Zlr  2.39, P  0.008, somes 7 and 20 and type 2 diabetes mellitus-associated
lod  2.08) and non-diabetic ESRD (Zlr  2.35, P  0.009, nephropathy in Pima Indians [9]. We reported evidence
lod  2.03). Additionally, the D10S677 peak was observed in
for linkage between markers on chromosome 10p andboth early onset (50 years) and late onset (50 years) ESRD
non-diabetic ESRD in African Americans [10]. These(Zlr  2.96, P  0.002, lod  2.82 in early onset and Zlr 
1.96, P  0.03, lod  1.60 in late onset ESRD families, respec- linkage analyses were performed using relatively small
tively). The lesser peak at D10S1435 was observed in families numbers of affected sibling pairs (98 in the Pima and
with non-diabetic etiologies of ESRD (Zlr  1.94, P  0.02, 129 in the African American study).
lod  1.58) and in those with early onset ESRD (Zlr  1.89,
Our interest in chromosome 10 was sparked by theP  0.03, lod  1.53).
detection of the human homolog of the rodent renalConclusions. These results suggest that the region near
D10S677, adjacent to the human homolog of the Rf1 gene, failure 1 gene (Rf1) on 10q [11]. To determine whether
contributes to ESRD susceptibility in African Americans. They the region containing the human homolog of Rf1, and
confirm that the region on 10p, near D10S1435, appears to be the previously identified linked markers on 10p, wereinvolved in early onset, non-diabetic etiologies of ESRD in
involved in ESRD susceptibility in African Americans,African Americans.
we re-evaluated polymorphic markers spanning chromo-
some 10 using an expanded collection of ESRD-affected
sib pairs.Evidence in favor of genetic susceptibility to human
end-stage renal disease (ESRD) was first suggested by
METHODS
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mapping, rodent renal failure-1 gene. The study population consisted of 356 African Ameri-
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ESRD (hypertension, renal-limited or systemic glomeru- lated under the exponential model with  constrained
between zero and two. Since human chromosome 10lar disorders, or unknown). Discordant etiologies of
ESRD were observed in the non-diabetic ESRD sib has been previously identified as containing renal failure
genes [11], significance of linkage was declared for lodpairs, as previously reported [1]. Exclusion criteria were
sibs in whom either member had ESRD attributed to scores greater than 1.17 (equivalent to a P value of 0.01).
Secondary analyses were performed with the data subdi-polycystic kidney disease, Alport syndrome (hereditary
nephritis) or urologic disease, age 18 years, inability vided either by underlying etiology of ESRD (diabetic
vs. non-diabetic) or by age at onset of renal complica-to provide informed consent, or self-reported race other
than African American. The vast majority of sib pairs tions. In the latter situation, the mean age at onset of
family members was computed, the families ranked, andlived in North Carolina, South Carolina and Georgia,
and were identified through family participation in the the median used to define a dichotomy (early vs. late).
Family-specific weights were assigned on the basis ofESRD Network 6/Southeastem Kidney Council, Inc.
“Family History of ESRD Study” [12]. etiology (diabetic vs. non-diabetic) or age at onset (early
vs. late). Multipoint linkage analyses were then repeated
Genotyping in the families using the weighting structure (family
weights of zero or one, based upon the clinical subset),Thirty microsatellite markers from CHLC/Weber hu-
man genome-wide screening set version 10 (http://www. effectively partitioning the families into subsets. In these
analyses, locations were identified in which the weightingchlc.org) [13] were used to scan chromosome 10, as pre-
viously described [10]. Distances between adjacent mark- resulted in an increase in log of the odds ratio (lod) score
greater than 1.44 over the initial (un-weighted) result.ers varied from 0.9 to 14.4 centiMorgans (cM) with an
average intermarker distance of 6.6 cM comprising a The increase in lod score [when multiplied by 21n(10)]
results in a statistic that is asymptotically distributed asmap with a total length of 186 cM. This comprised a
total of approximately 13,500 genotypes. Genotype anal- a 21 under the null hypothesis of “no heterogeneity.”
ysis was carried out on an ABI PRISM 3700 DNA The threshold of 1.44 corresponds to a P 0.01, approxi-
Analyzer (Applied BioSystems, Foster City, CA, USA) mately.
using GeneScan Analysis Software and prepared for
linkage analysis with ABI PRISM Genotype! Software.
RESULTSOligonucleotide primers (unlabeled, HEX-labeled, FAM-
Significant evidence for linkage was detected betweenlabeled) were purchased from Research Genetics (Hunts-
D10S677 and all-cause ESRD in the total population ofville, AL, USA). NED-labeled primers were purchased
356 African American sib pairs (lod  3.4, P  0.0004;from Applied BioSystems.
Fig. 1). D10S677 also demonstrated significant evidence
Statistical analyses for linkage to ESRD in sibs concordant for type 2 diabe-
tes mellitus-associated nephropathy (lod  2.08, P The family data were subjected to a series of analyses
0.008), and in sibs concordant for ESRD due to hyperten-for data quality and pedigree structure prior to formal
sion, chronic glomerular disorders and unknown etiolo-linkage analyses. First, the data were scanned routinely
gies of ESRD (lod  2.35, P  0.009; Fig. 2). Finally,to detect Mendelian inconsistencies, using PedCheck
D10S677 revealed evidence for linkage in sib pairs with[14]. Inconsistencies were removed either by re-genotyp-
mean age at ESRD onset 50 years (lod  2.82, P ing the specific marker or by coding the questionable
0.002) and in sib pairs with mean age at ESRD onsetmarker as “unknown” for that family. Second, the data
50 years (lod1.60, P  0.03; Fig. 3).were evaluated for potential errors in pedigree structure,
Our previous analysis in 129 African American sibusing PREST [15] and incorporating marker data from
pairs revealed suggestive evidence that D10S1435 wasmultiple chromosomes to enhance detection of inconsis-
linked to non-diabetic etiologies of ESRD [10]. The pres-tencies. For measures of marker allele sharing that ex-
ent analysis confirmed this result (Fig. 2). Linkage analy-ceeded the threshold of P  103 (by likelihood ratio
sis of D10S1435 revealed a lod score of 1.77 (P  0.04)statistics) and an empiric P  105 (by simulation), the
in the total population of ESRD sibs, a lod of 1.52 instructure of the family was altered to the most likely
sibs with non-diabetic ESRD (P  0.02) and a lod ofstructure. This procedure typically resulted in changing
1.53 (P  0.03) in sibs with early onset of ESRD (50a set of full siblings to include a half-sibling, including
years old). Although not reaching statistical significancea father with “unknown” phenotype and genotype to
(at the P  0.01 level), this region of chromosome 10pcomplete the family structure.
may warrant further exploration. The lack of linkage ofLinkage was assessed by nonparametric linkage meth-
D10S1435 to late onset and diabetic etiologies of ESRDods using the program GeneHunter-plus [16–18]. The
suggests evidence of linkage heterogeneity on chromo-multipoint linkage analyses were completed using the
S (pairs) option and maximized lod scores were calcu- some 10.
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Fig. 1. Multipoint linkage analysis of all-cause
end-stage renal disease for chromosome 10
markers.
Fig. 2. Multipoint linkage analysis of type 2
diabetes mellitus-associated end-stage renal
disease () versus nondiabetic end-stage re-
nal disease () for chromosome 10 markers.
DISCUSSION for linkage to all-cause ESRD, and to diabetic and non-
diabetic etiologies of ESRD, whereas neighboring mark-We detected significant evidence for linkage between
ers exhibited no evidence for linkage. This result maymarkers on human chromosome 10 and ESRD in this,
provide a biologic explanation for the clustering of multi-the largest, collection of African American sib pairs with
ple etiologies of ESRD in African American families.ESRD evaluated to date. The multipoint linkage analy-
Additionally, the lesser peak at D10S1435 (previouslyses of ESRD and etiologically-distinct subsets of ESRD
linked to non-diabetic ESRD in 71 sib pairs) maintainedprovided evidence of a strong nature (sharp linkage
significant evidence for linkage in these 199 sib pairs.peak) at the D10S677 locus. When analyzed individually,
the D10S677 marker demonstrated significant evidence Replication of linkage is a rarely observed but impor-
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Fig. 3. Multipoint linkage analysis of early
onset (50 years; ) versus late onset (50
years; ) end-stage renal disease for chromo-
some 10 markers.
tant component of genome screens. A genome scan for ESRD, and of D10S677 with both early and late onset
forms of ESRD is worthy of comment. Early onset formscreatinine clearance has recently been performed in
Utah kindreds with members having essential hyperten- of ESRD cluster more tightly in African American multi-
plex renal disease families than does late onset diseasesion and premature cardiovascular disease (Dr. Steven
Hunt, University of Utah, personal communication). Par- [12]. Early onset disease is also associated with an in-
creased sibling risk ratio, s (abstract; Simon et al, J Amticipating family members had three separate measure-
ments of creatinine clearance performed at several year Soc Nephrol 7:1343A, 1996). This linkage heterogeneity
supports the value of molecular genetic approaches tointervals (each sample was a timed 12-hour overnight
urine collection). The D10S677 marker and adjacent identifying the underlying etiologies of ESRD.
It should be noted that fewer than 5% of the sibs withmarkers demonstrated suggestive evidence for linkage
to creatinine clearance in these Utah families (maximum non-diabetic ESRD had renal biopsies performed prior
to reaching ESRD. This weakness in study design andlod score  2.0; P  0.002). When analyzed separately,
linkage was detected independently in all three timed limited phenotypic information affects most genetic, epi-
demiologic, and physiologic analyses in ESRD. We be-urine collections. The support intervals for linkage to
ESRD in our African American ESRD study population lieve that the repeated demonstration of multiple etiolo-
gies of ESRD within families supports the concept ofand for creatinine clearance in the Utah families overlap.
The linked region in both studies is proximal to the renal failure susceptibility genes (or genes regulating
progression of renal failure to end-stage) that are inde-human homolog of the rodent Rfl gene. The human
homolog of the Rf1 gene likely lies in the 10q24-q26 pendent of the factors that initiate the systemic disease
processes of high blood pressure or hyperglycemia. Theinterval (Dr. Howard J. Jacob, Medical College of Wis-
consin, personal communication) based on comparative large number of sib pairs evaluated in this report pro-
vided sufficient power for us to identify markers linkedmapping of Rf1-linked genes on the rat and human ge-
nomes. Broeckel et al reported that haplotypes of the to both diabetic and non-diabetic ESRD.
Based upon evidence of linkage in two diverse popula-Rf1 region on human chromosome 10 were associated
with hypertensive ESRD in unrelated African Americans tions (African Americans from the southeast and Cauca-
sians from Utah), we conclude that at least one gene(abstract; Broeckel et al, J Am Soc Nephrol 10:431A,
1999). Since our markers do not precisely align with the that increases susceptibility to ESRD and impacting cre-
atinine clearance resides on human chromosome 10q.Rf1 region, it is unclear if Rf1 or a nearby gene(s) ac-
counts for the linkage. This gene(s) is adjacent to the human homolog of the
rodent Rf1 gene. Efforts to positionally clone these genesThe linkage of D10S1435 solely with early onset
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encoding alpha-actinin-4, cause familial focal segmental glomerulo-are underway with a current focus on creation of a dense
sclerosis. Nat Genet 24:251–256, 2000
SNP (single nucleotide polymorphism) map in the re- 6. Winn MP, Conlon PJ, Lynn KL, et al: Linkage of a gene causing
familial focal glomerulosclerosis to chromosome 11 and furthergions of the D10S677 and D10S1435 peaks as tools for
evidence of genetic heterogeneity. Genomics 58:113–120, 1999fine mapping of these regions using association analysis. 7. Tsukaguchi H, Vager H, Dawbom J, et al: A locus for adolescent
and adult onset familial focal segmental glomerulosclerosis on
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